 vs bare expandable stents for the
treatment of aortoiliac occlusive disease. J Vasc Surg 2011;54:
1561-70.
142. Rzucidlo EM, Powell RJ, Zwolak RM, Fillinger MF, Walsh DB,
Schermerhorn ML, et al. Early results of stent-grafting to treat diffuse
aortoiliac occlusive disease. J Vasc Surg 2003;37:1175-80.
143. Huded CP, Goodney PP, Powell RJ, Nolan BW, Rzucidlo EM,
Simone ST, et al. The impact of adjunctive iliac stenting on femoralfemoral bypass in contemporary practice. J Vasc Surg 2012;55:
739-45.
144. Chang RW, Goodney PP, Baek JH, Nolan BW, Rzucidlo EM, et al.
Long-term results of combined common femoral endarterectomy and
iliac stenting/stent grafting for occlusive disease. J Vasc Surg
2008;48:362-7.
145. Brewster DC. Clinical and anatomical considerations for surgery in
aortoiliac disease and results of surgical treatment. Circulation
1991;83(2 Suppl):I42-52.
146. Rutherford RB. Aortobifemoral bypass, the gold standard: technical
considerations. Semin Vasc Surg 1994;7:11-6.
147. Hallisey MJ, Meranze SG, Parker BC, Rholl KS, Miller WJ,
Katzen BT, et al. Percutaneous transluminal angioplasty of the
abdominal aorta. J Vasc Interv Radiol 1994;5:679-87.
148. Feugier P, Toursarkissian B, Chevalier JM, Favre JP. Endovascular
treatment of isolated atherosclerotic stenosis of the infrarenal
abdominal aorta: long-term outcome. Ann Vasc Surg 2003;17:
37